Structures by: Penthala N. R.
Total: 35
13-(<i>E</i>)-(2-Aminobenzylidene)parthenolide
C21H25NO3
Acta Crystallographica Section E (2018) 74, 11 1543-1546
a=11.6136(3)Å b=6.24030(10)Å c=12.6875(3)Å
α=90° β=104.3850(10)° γ=90°
(<i>Z</i>)-5-[2-(Benzo[<i>b</i>]thiophen-3-yl)-1-(3,4,5-trimethoxyphenyl)ethenyl]-1<i>H</i>-tetrazole
C20H18N4O3S
Acta Crystallographica Section E (2016) 72, 5 652-655
a=4.88880(10)Å b=24.6650(6)Å c=15.5956(4)Å
α=90° β=91.0310(10)° γ=90°
(<i>Z</i>)-5-[2-(Benzo[<i>b</i>]thiophen-2-yl)-1-(3,5-dimethoxyphenyl)ethenyl]-1<i>H</i>-tetrazole methanol monosolvate
C19H16N4O2S,CH4O
Acta Crystallographica Section E (2016) 72, 5 652-655
a=18.2226(4)Å b=13.7954(5)Å c=15.5594(5)Å
α=90° β=90° γ=90°
4,5-Bis(3,4,5-trimethoxyphenyl)-2<i>H</i>-1,2,3-triazole methanol solvate
C20H23N3O6,CH4O
Acta Crystallographica Section E (2014) 70, 10 o1128-o1129
a=10.14580(10)Å b=10.60900(10)Å c=11.0435(2)Å
α=89.5708(6)° β=72.5903(6)° γ=70.7146(7)°
4,4'-Bis[3-(pyrrolidin-1-yl)prop-1-yn-1-yl]-1,1'-biphenyl
C26H28N2
Acta Crystallographica Section E (2015) 71, 10 1147-1150
a=6.21000(10)Å b=10.3089(2)Å c=16.3082(3)Å
α=86.3170(10)° β=81.2020(10)° γ=76.6710(10)°
4,4'-Bis{3-[(<i>S</i>)-2-methylpyrrolidin-1-yl]prop-1-yn-1-yl}-1,1'-biphenyl
C28H32N2
Acta Crystallographica Section E (2015) 71, 10 1147-1150
a=8.1411(4)Å b=7.3080(4)Å c=18.9840(9)Å
α=90° β=98.177(3)° γ=90°
(<i>E</i>)-13-(Pyrimidin-5-yl)parthenolide
C19H22N2O3
Acta Crystallographica Section E (2015) 71, 12 1536-1538
a=10.3526(2)Å b=7.26120(10)Å c=11.9198(2)Å
α=90° β=108.1210(6)° γ=90°
4-(Benzo[<i>b</i>]thiophen-2-yl)-5-(3,4,5-trimethoxyphenyl)-2<i>H</i>-1,2,3-triazole
C19H17N3O3S
Acta Crystallographica Section E (2014) 70, 11 392-395
a=11.8983(2)Å b=8.18600(10)Å c=18.4582(3)Å
α=90° β=105.5046(7)° γ=90°
4-(Benzo[<i>b</i>]thiophen-2-yl)-2-methyl-5-(3,4,5-trimethoxyphenyl)-2<i>H</i>-1,2,3-triazole
C20H19N3O3S
Acta Crystallographica Section E (2014) 70, 11 392-395
a=8.85790(10)Å b=11.07610(10)Å c=11.26260(10)Å
α=106.859(4)° β=111.668(5)° γ=105.498(4)°
4,4'-Bis[3-(2,2,6,6-tetramethylpiperidin-1-yl)prop-1-yn-1-yl]-1,1'-biphenyl
C36H48N2
Acta Crystallographica Section E (2015) 71, 10 1132-1135
a=16.0591(3)Å b=6.22670(10)Å c=15.5921(3)Å
α=90° β=100.8950(10)° γ=90°
4,4'-Bis[3-(4-methylpiperidin-1-yl)prop-1-yn-1-yl]-1,1'-biphenyl
C30H36N2
Acta Crystallographica Section E (2015) 71, 10 1132-1135
a=21.9870(6)Å b=7.0390(3)Å c=15.7840(11)Å
α=90° β=99.0310(19)° γ=90°
(<i>Z</i>)-3-(1-Benzofuran-2-yl)-2-(3,4,5-trimethoxyphenyl)acrylonitrile
C20H17NO4
Acta crystallographica. Section E, Structure reports online (2012) 68, Pt 3 o731
a=28.0892(5)Å b=6.95550(10)Å c=20.0908(4)Å
α=90.00° β=122.6780(10)° γ=90.00°
(<i>Z</i>)-4-[3-(2,5-Dioxoimidazolidin-4-ylidenemethyl)-1<i>H</i>-indol- 1-ylmethyl]benzonitrile
C20H14N4O2
Acta Crystallographica Section E (2008) 64, 11 o2122
a=18.8495(16)Å b=7.6812(7)Å c=24.322(2)Å
α=90.00° β=110.939(3)° γ=90.00°
(<i>Z</i>)-Methyl 4-[3-(3-oxoquinuclidin-2-ylidenemethyl)-1<i>H</i>-indol-1-ylmethyl]benzoate
C25H24N2O3
Acta Crystallographica Section E (2008) 64, 11 o2050
a=9.8597(3)Å b=10.3037(3)Å c=11.3515(4)Å
α=106.6470(14)° β=111.4372(13)° γ=92.7863(15)°
(<i>Z</i>)-4-[3-(3-Oxoquinuclidin-2-ylidenemethyl)-1<i>H</i>-indol-1- ylmethyl]benzonitrile
C24H21N3O
Acta Crystallographica Section E (2008) 64, 11 o2049
a=9.0627(2)Å b=10.7959(3)Å c=11.6969(4)Å
α=99.1571(13)° β=106.0935(14)° γ=113.7908(14)°
(<i>Z</i>)-Methyl 4-({3-[(2,5-dioxoimidazolidin-4-ylidene)methyl]-1<i>H</i>- indol-1-yl}methyl)benzoate
C21H17N3O4
Acta Crystallographica Section E (2009) 65, 1 o62-o63
a=7.63900(10)Å b=8.00130(10)Å c=15.0405(3)Å
α=91.9853(9)° β=96.2291(9)° γ=104.4242(9)°
3-(2-Amino-1-methyl-4-oxo-4,5-dihydro-1<i>H</i>-imidazol-5-yl)-3- hydroxyindolin-2-one monohydrate
C12H12N4O3,H2O
Acta Crystallographica Section E (2009) 65, 3 o552
a=8.35140(10)Å b=10.7166(2)Å c=13.9679(2)Å
α=90.00° β=104.7550(10)° γ=90.00°
<i>rac</i>-2-(2-amino-4-oxo-4,5-dihydro-1,3-thiazol-5-yl)-2-hydroxyindane- 1,3-dione
C12H8N2O4S
Acta Crystallographica Section E (2009) 65, 8 o1877
a=14.1702(2)Å b=5.67130(10)Å c=14.8296(3)Å
α=90.00° β=114.0171(9)° γ=90.00°
1-Benzylpyrrolidine-2,5-dicarbonitrile
C13H13N3
Acta Crystallographica Section E (2011) 67, 4 o747
a=10.9898(3)Å b=9.4494(2)Å c=11.4768(3)Å
α=90.00° β=103.0735(11)° γ=90.00°
(2<i>Z</i>,3<i>E</i>)-2-{[1-(4-Chlorobenzyl)-1<i>H</i>-indol-3- yl]methylidene}quinuclidin-3-one oxime
C23H22ClN3O
Acta Crystallographica Section E (2011) 67, 3 o735
a=5.83820(10)Å b=10.7005(2)Å c=30.9451(6)Å
α=90.00° β=90.00° γ=90.00°
(<i>Z</i>)-2-Amino-5-[2,4-dimethoxy-6-(4-methoxystyryl)benzylidene]-1,3- thiazol-4(5<i>H</i>)-one methanol solvate
C21H20N2O4S,CH4O
Acta Crystallographica Section E (2010) 66, 7 o1792
a=10.6243(2)Å b=22.2530(5)Å c=9.0562(2)Å
α=90.00° β=93.0280(10)° γ=90.00°
<i>cis</i>)-2,5-Bis(2-fluoro-5-methoxyphenethyl)pyrrolidinium formate
C22H28F2NO2,CHO2
Acta Crystallographica Section E (2011) 67, 3 o737
a=7.83380(10)Å b=27.8759(3)Å c=29.3202(3)Å
α=90.00° β=90.00° γ=90.00°
3-(2-Amino-1-methyl-4-oxo-4,5-dihydro-1<i>H</i>-imidazol-5-yl)-3-hydroxy-1- phenylindolin-2-one ethanol solvate
C18H16N4O3,C2H6O
Acta Crystallographica Section E (2009) 65, 10 o2439-o2440
a=7.49120(10)Å b=11.0018(2)Å c=12.0835(2)Å
α=78.1520(10)° β=74.4130(10)° γ=74.0900(10)°
3-(2-Amino-1-methyl-4-oxo-4,5-dihydro-1<i>H</i>-imidazol-5-yl)- 5-fluoro-3-hydroxy-1-methylindolin-2-one methanol hemisolvate
C13H13FN4O3,0.5(CH4O)
Acta Crystallographica Section E (2009) 65, 11 o2909-o2910
a=14.3088(3)Å b=10.7900(2)Å c=18.1286(5)Å
α=90.00° β=107.6760(10)° γ=90.00°
(<i>E</i>,<i>E</i>)-1-Methyl-2,6-distyrylpyridinium iodide
C22H20N,I
Acta Crystallographica Section E (2010) 66, 7 o1793
a=18.7309(4)Å b=9.5687(2)Å c=19.9829(4)Å
α=90.00° β=90.2790(10)° γ=90.00°
(<i>Z</i>)-3-(1<i>H</i>-Indol-3-yl)-2-(3,4,5-trimethoxyphenyl)acrylonitrile
C20H18N2O3
Acta Crystallographica Section E (2012) 68, 3 o729
a=11.3384(4)Å b=21.1383(8)Å c=6.9570(3)Å
α=90.00° β=93.610(2)° γ=90.00°
(<i>E</i>)-13-(4-Aminophenyl)parthenolide
C21H25NO3
Acta Crystallographica Section E (2013) 69, 11 o1709-o1710
a=8.56190(10)Å b=11.8846(2)Å c=17.7457(3)Å
α=90° β=90° γ=90°
13-(Imidazol-1-yl)-11,13-dihydromelampomagnolide B monohydrate
C18H24N2O4,H2O
Acta Crystallographica Section E (2013) 69, 12 o1734-o1735
a=9.8073(2)Å b=8.27840(10)Å c=10.7741(2)Å
α=90° β=95.0150(10)° γ=90°
13-(<i>N</i>,<i>N</i>-Dimethylamino)micheliolide 0.08-hydrate
C17H27NO3,0.08(H2O)
Acta Crystallographica Section E (2013) 69, 12 o1789-o1790
a=9.1329(2)Å b=10.5227(2)Å c=16.7194(3)Å
α=90° β=90° γ=90°
<i>rac</i>-(<i>Z</i>)-Methyl 1-benzyl-3-[(3-hydroxyquinuclidin-2-ylidene)methyl]-1<i>H</i>-indole-6- carboxylate
C25H26N2O3
Acta Crystallographica Section E (2012) 68, 11 o3111
a=6.16190(10)Å b=10.3119(2)Å c=16.5959(3)Å
α=75.6705(7)° β=80.0939(7)° γ=85.9410(7)°
1-Benzyl-3-hydroxy-3-(2-imino-3-methyl-5-oxoimidazolidin-4-yl)- 2,3-dihydro-1<i>H</i>-indol-2-one
C19H18N4O3
Acta Crystallographica Section E (2013) 69, 2 o290-o291
a=13.4466(2)Å b=10.6921(2)Å c=27.2057(5)Å
α=90.00° β=90.00° γ=90.00°
1-Benzyl-5-bromo-3-hydroxy-3-(2-imino-3-methyl-5-oxoimidazolidin-4-yl)- 2,3-dihydro-1<i>H</i>-indol-2-one ethanol monosolvate
C19H17BrN4O3,C2H6O
Acta Crystallographica Section E (2013) 69, 2 o288-o289
a=7.8384(16)Å b=24.553(5)Å c=10.936(2)Å
α=90.00° β=99.54(3)° γ=90.00°
Melampomagnolide B
C19H24O7
Acta Crystallographica Section E (2014) 70, 3 o372-o373
a=8.7866(2)Å b=9.6082(2)Å c=21.0088(5)Å
α=90° β=90° γ=90°
(<i>E</i>)-13-(2-Bromophenyl)micheliolide
C21H23BrO3
Acta Crystallographica Section E (2014) 70, 3 o251-o252
a=7.16170(10)Å b=13.1615(2)Å c=19.2306(3)Å
α=90° β=90° γ=90°
(<i>E</i>)-13-{4-[(<i>Z</i>)-2-Cyano-2-(3,4,5-\ trimethoxyphenyl)ethenyl]phenyl}parthenolide methanol hemisolvate
C33H35NO6,0.5(CH4O)
Acta Crystallographica Section E (2014) 70, 10 o1092-o1093
a=9.3347(2)Å b=16.2442(3)Å c=19.2580(4)Å
α=90° β=90° γ=90°